Check your medicines with a pharmacist before starting any herbal supplement.
Who Should Not Take CortiSync? 8 Groups to Check First
Answer first: who should not take CortiSync without a doctor or pharmacist approving it first? Pregnant or breastfeeding women, people with liver or thyroid conditions, anyone on diabetes, blood-pressure, sedative, seizure or immune-suppressing medicine, and anyone facing surgery. The official page lists none of this, so this checklist fills the gap. See the official CortiSync page.
Affiliate disclosure: links to CortiSync on this page are affiliate links (code 618161). We may earn a commission at no extra cost to you. This article is educational and is not medical advice.
Contents
What the Official CortiSync Page Says About Safety
Most buyers ask one thing: who should not take CortiSync? We read the manufacturer’s page on 2026-10-14 to see whether it answers that. It does not. It describes the formula as reviewed by its team doctor and gives the dosage: 2 capsules daily with a meal.
The same page states that no side effects have been reported and calls each ingredient free of known risks. It gives no source for either statement. It also says nothing about pregnancy, medications, age limits or when to see a doctor.
That silence is the reason this guide exists. A missing warning is not proof of safety. It only means the buyer has to check elsewhere before ordering. Open the official page and compare it with the checklist below.
How We Built This “Who Should Not Take CortiSync” Checklist
No published trial tested the finished CortiSync capsule. So we worked ingredient by ingredient, using only pages we opened: NIH fact sheets, the NIH LiverTox database, and PubMed records. Where we found no official page for an ingredient, we say so.
To decide who should not take CortiSync, start with the label. It lists seven actives. We read the supplement facts image on 2026-10-11 and re-checked it on 2026-10-12. Serving size is 2 capsules, 30 servings per container.
| Ingredient (per 2 capsules) | Amount on the label |
|---|---|
| Sensoril ashwagandha root extract | 300 mg |
| Lemon balm herb powder | 150 mg |
| Lichi fruit extract | 120 mg |
| L-theanine | 100 mg |
| Holy basil leaf extract (2% ursolic acid) | 100 mg |
| Magnolia bark extract | 100 mg |
| Rhodiola rosea root extract (3% rosavins, 1% salidroside) | 50 mg |
Ashwagandha is the ingredient with the most safety guidance, so most cautions below come from it. For the full formula breakdown see our CortiSync safety review and dosage guide.
Who Should Not Take CortiSync: The 8 Groups
This list of who should not take CortiSync comes from the NIH pages on ashwagandha and rhodiola, which are the two ingredients with published cautions. They apply to the ingredients, not to a proven problem with the finished product. Use them as a list of questions for your pharmacist.
1. who should not take CortiSync: pregnant or breastfeeding women
The National Center for Complementary and Integrative Health (NCCIH) advises avoiding ashwagandha during pregnancy and says it should not be used while breastfeeding. The NIH Office of Dietary Supplements adds that some experts advise avoidance because of reports of spontaneous abortion, a claim another body disputes.
For rhodiola, NCCIH says little is known about safety in pregnancy and breastfeeding. The official CortiSync page is silent on both. Our cortisol supplements for women guide covers this gap in more detail.
2. who should not take CortiSync: people with liver disease or past liver injury
LiverTox, the NIH liver-injury database, rates ashwagandha a “likely cause” of clinically apparent liver injury. Injury usually appears 2 to 12 weeks after starting. It is often cholestatic, with jaundice and itching, and most cases resolve within 1 to 4 months of stopping.
Fatal cases and transplants occurred mainly in people with existing liver disease. LiverTox says use should be avoided in cirrhosis or advanced chronic liver disease. The NIH supplement fact sheet notes that many case reports involved combination products with unverified contents.
3. who should not take CortiSync: people with thyroid disorders or thyroid medicine
NCCIH says ashwagandha is not recommended for autoimmune or thyroid disorders. The NIH fact sheet reports small T4 increases in one study, lower TSH in a subclinical hypothyroidism trial, and thyrotoxicosis in case reports. It also lists thyroid hormone medicines as a possible interaction.
4. who should not take CortiSync: people with autoimmune disease or on immunosuppressants
NCCIH lists immunosuppressants among the possible ashwagandha interactions and does not recommend it for autoimmune conditions. If you take medicine to calm your immune system after a transplant or for an autoimmune disease, your prescriber should approve any herbal extract first.
5. who should not take CortiSync: people on diabetes or blood-pressure medicine
Both NCCIH and the NIH fact sheet list diabetes and blood-pressure medicines as possible interactions with ashwagandha. For rhodiola, NCCIH reports an interaction with losartan, a blood-pressure drug. Stacking several herbs with such medicines is exactly what a pharmacist should review.
6. who should not take CortiSync: people on sedatives or seizure medicine
Sedatives and anticonvulsants appear on the NCCIH interaction list for ashwagandha, which can itself cause drowsiness. The formula also contains L-theanine, lemon balm and magnolia, which are marketed for calm. We did not open a safety page for those three, so check them with your pharmacist.
7. who should not take CortiSync: anyone with surgery coming up
NCCIH says ashwagandha is not recommended for people about to have surgery. The NIH general guidance adds that some supplements affect bleeding or anesthesia and that you should tell your care team about every supplement well in advance.
8. who should not take CortiSync: men with hormone-sensitive prostate cancer
NCCIH advises avoiding ashwagandha in hormone-sensitive prostate cancer because it may raise testosterone. The official page markets the formula to men in their late 30s to 50s, which makes this caution relevant for the exact audience it targets.
Quick Summary Table: Who Should Not Take CortiSync Without Advice
| Group | Source of the caution | Practical step |
|---|---|---|
| Pregnant or breastfeeding | NCCIH (ashwagandha); NIH ODS; NCCIH (rhodiola: little known) | Skip unless your obstetrician agrees |
| Liver disease | LiverTox; NIH ODS | Ask your hepatologist; avoid in cirrhosis |
| Thyroid disorder or thyroid medicine | NCCIH; NIH ODS | Ask your prescriber; discuss lab monitoring |
| Autoimmune or immunosuppressants | NCCIH | Prescriber approval first |
| Diabetes or blood-pressure drugs | NCCIH; NIH ODS; NCCIH (rhodiola, losartan) | Pharmacist interaction check |
| Sedatives or seizure drugs | NCCIH | Pharmacist interaction check |
| Upcoming surgery | NCCIH; NIH general guidance | Tell the surgical team early |
| Hormone-sensitive prostate cancer | NCCIH | Avoid unless your oncologist agrees |
Ingredient-by-Ingredient Safety Table
This table separates what we confirmed from what we could not. “Not checked” means we did not open an authoritative safety page in this review, not that the ingredient is unsafe.
| Ingredient | Confirmed from opened sources | Not confirmed |
|---|---|---|
| Sensoril ashwagandha | Short-term use up to about 3 months seems tolerated; rare liver injury; thyroid, pregnancy, surgery and medicine cautions | Long-term safety; the safety of this specific Sensoril extract |
| Rhodiola | “Possibly safe” up to 12 weeks; dizziness, headache, insomnia, dry mouth or excess saliva; losartan interaction | Pregnancy and breastfeeding safety |
| Holy basil | One 8-week trial in 100 stressed adults (PMID 36185698) tested a different branded extract | Interaction profile |
| Lemon balm | Not checked | Interaction and sedation data |
| L-theanine | Not checked | Interaction data |
| Magnolia bark | Not checked | Interaction and sedation data |
| Lichi fruit extract | Not checked | Safety data |
For who should not take CortiSync, five of the seven ingredients are in the “not checked” or “not confirmed” column. That is why a pharmacist review, using the printed label, is worth the ten minutes it takes.
What Human Trials Say About Tolerability
A 60-day randomized trial in 60 stressed adults gave 240 mg daily of a standardized ashwagandha extract (Shoden) or placebo, and measured anxiety scales and cortisol (PMID 31517876). It is an efficacy study, not an interaction study, and used a different extract and dose from the label.
An 8-week, double-blind trial of 100 volunteers aged 18 to 65 tested 125 mg of a holy basil extract twice daily against placebo (PMID 36185698). It reported better perceived stress and sleep scores. Again, it tested a different product, so we treat it as ingredient context only.
For safety, who should not take CortiSync matters more than efficacy, and small, short trials rarely detect rare events like liver injury. The NIH fact sheet states that ashwagandha studies are mostly small and short-term. See our three-study review and Sensoril vs KSM-66 comparison for efficacy detail.
Warning Signs and What to Do If You Already Take It
Even outside the list of who should not take CortiSync, effects can occur. NCCIH lists drowsiness, stomach upset, diarrhea and vomiting as possible ashwagandha effects. Rhodiola may cause dizziness, headache, insomnia, and dry mouth or extra saliva. Mild effects are common to herbal products and are not a diagnosis.
Yellow skin or eyes, dark urine, itching or unusual tiredness need prompt medical attention, because these match the pattern LiverTox describes. NCCIH advises stopping a supplement that causes side effects and contacting your provider.
You can also report a safety concern through the HHS Safety Reporting Portal, as NCCIH explains in its guide to using supplements wisely. Bring the bottle, the label image and the dates you started.
Who CortiSync May Suit, and an Honest Verdict
The manufacturer states that CortiSync is taken as 2 capsules daily with a meal, that each bottle is a one-month supply, and that it suggests starting with at least three months. It also states a 67-day money-back guarantee. These are the manufacturer’s statements and we have not verified them.
If none of the groups of who should not take CortiSync applies to you, your pharmacist sees no conflict, and you want a seven-ingredient stress formula, CortiSync is a reasonable option to review. If any group applies, the safer choice is to wait for medical clearance. Compare alternatives in our CortiSync comparison.
A Safer Way to Start: Pharmacist Checklist
Knowing who should not take CortiSync is only half the job, so print the label from the official page and list every medicine you take. Ask the pharmacist whether any ingredient conflicts with them. Start only after clearance, and keep the 67-day guarantee window in mind if your clinician says stop.
Anyone in the groups of who should not take CortiSync should wait for clearance. Everyone else can keep notes on sleep, digestion and energy for the first weeks. Stop and call a professional if something new appears. Our effectiveness review, benefits guide and cortisol supplement questions hub answer related questions.
Medical disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is educational, not medical advice. Consult a qualified professional before using any supplement, especially if you are pregnant, take medicine or have a medical condition.
FAQ: who should not take CortiSync?
Who should not take CortiSync?
Pregnant or breastfeeding women, people with liver, thyroid or autoimmune conditions, those on diabetes, blood-pressure, sedative, seizure or immunosuppressant medicine, people facing surgery, and men with hormone-sensitive prostate cancer should get professional advice first. These cautions come from NIH pages on its ingredients.
Does the official CortiSync page list contraindications?
On 2026-10-14 the page did not mention pregnancy, medications, age limits or when to see a doctor. It states that no side effects have been reported, without citing a source.
Is CortiSync safe during pregnancy?
The manufacturer page is silent. NCCIH advises avoiding ashwagandha in pregnancy, and little is known about rhodiola. Pregnant women should skip it unless their obstetrician approves.
Can I take CortiSync with blood-pressure or diabetes medicine?
NCCIH lists both drug classes as possible ashwagandha interactions and reports a rhodiola interaction with losartan. Ask a pharmacist to review your exact medicines before starting.
Can CortiSync affect the liver?
Rare liver injury has been linked to ashwagandha products. LiverTox says onset is usually 2 to 12 weeks after starting and most cases resolve after stopping. People with liver disease should avoid it. No study tested the finished CortiSync capsule.
Is CortiSync safe with thyroid medicine?
NCCIH does not recommend ashwagandha for thyroid disorders, and the NIH fact sheet lists thyroid hormone medicines as a possible interaction. Discuss monitoring with your prescriber first.
Should I stop CortiSync before surgery?
NCCIH says ashwagandha is not recommended for people about to have surgery. Tell your surgical team about it well in advance and follow their advice.
Can men and women both take it?
The official page markets to men in their late 30s to 50s and does not state an age limit. Women who are pregnant or breastfeeding should avoid it without medical approval. Adults without risk factors should still check with a pharmacist.
What are the possible side effects?
NCCIH lists drowsiness, stomach upset, diarrhea and vomiting for ashwagandha, and dizziness, headache, insomnia and dry mouth for rhodiola. Stop and contact a professional if symptoms are strong or persistent.
Reviewed By
Reviewed for supplement safety and drug-interaction accuracy by Dr. John Carter, PharmD, clinical pharmacist and lead scientific reviewer at HealthySupplements.us. The review covers the cautions and sources cited here, not a personal recommendation for any reader.
Authority Sources We Opened
- NCCIH: Ashwagandha
- NIH LiverTox: Ashwagandha
- NCCIH: Rhodiola
- NIH ODS: Ashwagandha fact sheet
- NIH ODS: Dietary supplements, what you need to know
- NCCIH: Using dietary supplements wisely
- Examine: Ashwagandha
- NIMH: I’m so stressed out fact sheet
- PubMed 31517876: Ashwagandha 60-day trial
- PubMed 36185698: Holy basil 8-week trial
- PubMed 32021735: Ashwagandha dose trial
- PubMed 31623400: Ashwagandha stress trial
